ZIOPHARM Oncology (ZIOP) Posts Q3 Loss of $0.13, Better Y/Y
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reports Q3 loss of $0.13, compared to ($0.26) in the same quarter last year.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
